Federal Contractor Profile
Illinois Institute Of Technology
$61M obligated·136 awards·5 agencies·17 NAICS
Federal Contracts
Showing award actions 1–50 of 188 funded award actions, most recent first.
- Contracts with positive obligations
- 136
- Funded award actions shown
- 188
- Obligations shown
- $61M
- Awarding agencies
- 5
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of September 28, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Sep 16, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98026F00003 | 541715 | IITRI - 2026 SF IND-ENABLING GLP TOXICOLOGY STUDIES | $46K |
| Sep 11, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98026F00002 | 541715 | IITRI - PA1 TASK ORDER #07 | $109K |
| Aug 11, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541715 | FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS | $35K |
| Jul 29, 2026 | Department of Health and Human ServicesNIH NCI | 75N91022C00010 | 541715 | PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | $550K |
| Jul 23, 2026 | Department of DefenseNAVAL SERVICE TRAINING COMMAND | N3560A26FB228 | 611310 | RATIFICATION OF GOVERNMENT-AT-FAULT RETROACTIVE TUITION FOR FALL SEMESTER 2025 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES. | $633K |
| Jun 30, 2026 | Department of Health and Human ServicesNIH NCI | 75N91024F00003 | 541715 | TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102 | $60K |
| Jun 26, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98026F00001 | 541715 | TASK ORDER AWARD- SSL GLP AND NON-GLP TOXICOLOGY STUDIES | $3.4M |
| Jun 22, 2026 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A26FA127 | 611310 | TUITION AND FEES | $11K |
| Jun 11, 2026 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A26FA468 | 611310 | TUITOIN AND FEES | $24K |
| May 27, 2026 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A26FA441 | 611310 | TUITION AND FEES | $26K |
| Apr 2, 2026 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25FA345 | 611310 | TUITION AND FEES | $3K |
| Mar 27, 2026 | Department of Health and Human ServicesNIH NCI | 75N91022C00010 | 541715 | PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | $10K |
| Feb 25, 2026 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00001 | 541715 | IITRI - PERFORMANCE AREA 1 TO2 | $46K |
| Feb 23, 2026 | Department of DefenseNAVAL SERVICE TRAINING COMMAND | N3560A26FB120 | 611310 | SPRING 2026 NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES. | $693K |
| Feb 6, 2026 | Department of Health and Human ServicesNIH NCI | 75N91026F00001 | 541715 | TOXICOLOGY STUDIES IN MICE ADMINISTERED MTX-531 - FINAL DELIVERABLES | $68K |
| Jan 30, 2026 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A26FA127 | 611310 | TUITION AND FEES | $10K |
| Oct 16, 2025 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25FA056 | 611310 | IL, ILLINOIS INSTITUTE OF TECHNOLOGY SPR 1301228229 TUITION AND FEES | $11K |
| Sep 25, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95025F00001 | 541715 | PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIES | $401K |
| Aug 27, 2025 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25F00D5 | 611310 | TUITION AND FEES | $700 |
| Jul 10, 2025 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25FA345 | 611310 | TUITION AND FEES | $9K |
| May 22, 2025 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25F00C2 | 611310 | TUITION AND FEES | $6K |
| May 7, 2025 | Department of DefenseNAVAL SERVICE TRAINING COMMAND | N3560A25FB119 | 611310 | TYPE RATIFICATION OF GOVERNMENT-AT-FALUT RETROACTIVE TUITION FOR SPRING SEMESRTER 2025 OF ORIGINAL LIABILITY) NROTC MIDSHIPMEN TUITION AND ALLOWABLE FEES FOR TWENTY MIDN | $544K |
| Apr 1, 2025 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25FA177 | 611310 | IL, ILLINOIS INSTITUTE OF TECHNOLOGY TUITION AND FEES FOR SUMMER TERM MAY - AUG 2025 | $26K |
| Mar 19, 2025 | Department of Health and Human ServicesNIH NCI | 75N91024F00002 | 541715 | TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531 | $451K |
| Mar 13, 2025 | Department of Health and Human ServicesNIH NCI | 75N91022C00010 | 541715 | PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | $10K |
| Feb 25, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00001 | 541715 | IITRI - PERFORMANCE AREA 1 TO2 | $85K |
| Feb 19, 2025 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25FA056 | 611310 | IL, ILLINOIS INSTITUTE OF TECHNOLOGY SPR 1301228229 TUITION AND FEES | $16K |
| Jan 16, 2025 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00001 | 541712 | NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020. | $51K |
| Jan 13, 2025 | Department of DefenseNAVAL SERVICE TRAINING COMMAND | N3560A25F00G1 | 611310 | EDUCATIONAL SERVICES AGREEMENT | $509K |
| Nov 13, 2024 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25F00D5 | 611310 | TUITION AND FEES | $11K |
| Nov 12, 2024 | Department of DefenseNAVY MEDICINE PROFESSIONAL | N0622A25F00C2 | 611310 | TUITION AND FEES | $16K |
| Nov 5, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541715 | IITRI - PTTP DRF BPN STUDY - TO3 | $218K |
| Sep 16, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541715 | FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS | $512K |
| Sep 6, 2024 | Department of Health and Human ServicesNIH NCI | 75N91024F00003 | 541715 | TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102 | $568K |
| Sep 5, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00003 | 541715 | IITRI -DOG MTD-DRF STUDIES-TO 4 | $14K |
| Aug 30, 2024 | Department of Health and Human ServicesNIH NCI | 75N91020F00001 | 541714 | TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022 | $154K |
| Jul 31, 2024 | Department of Health and Human ServicesNIH NCI | 75N91020F00001 | 541714 | PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER | $1.0M |
| Jul 23, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00004 | 541715 | IITRI - NON-GLP DOSE RANGE FINDING (DRF) STUDIES-DEC. 2023 #2 | $202K |
| Jul 22, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00002 | 541712 | TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022. | $55K |
| Jun 21, 2024 | Department of Health and Human ServicesNIH NCI | 75N91022C00010 | 541715 | PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | $375K |
| Jun 21, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541715 | IITRI - PTTP DRF BPN STUDY - TO3 | $56K |
| Jun 10, 2024 | Department of Health and Human ServicesNIH NCI | 75N91024F00002 | 541715 | TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531 | $1.3M |
| Jun 3, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00002 | 541712 | TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022. | $79K |
| May 7, 2024 | Department of DefenseNAVAL SERVICE TRAINING COMMAND | N3560A24F00B3 | 611310 | EDUCATIONAL SERVICES AGREEMENT | $325K |
| Mar 25, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00001 | 541712 | NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020. | $35K |
| Mar 14, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00003 | 541715 | IITRI -DOG MTD-DRF STUDIES-TO 4 | $211K |
| Mar 12, 2024 | Department of Health and Human ServicesNIH NCI | 75N91022C00010 | 541715 | PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS | $301K |
| Mar 1, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00001 | 541715 | IITRI - PERFORMANCE AREA 1 TO2 | $82K |
| Mar 1, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95024F00002 | 541715 | IITRI - PTTP DRF BPN STUDY - TO3 | $164K |
| Feb 20, 2024 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA | 75N95020F00002 | 541712 | TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022. | $9K |
Get Alerted Before Illinois Institute Of Technology's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free